Inventor
ENSCORE DAVID J
US25 patents
⚠️ This page may combine multiple inventors who share the name “ENSCORE DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALZA CORP
20 patentsUS4904475AFeb 27, 1990
Transdermal delivery of drugs from an aqueous reservoir
ALZA CORP148 citations99
US4645502AFeb 24, 1987
Transdermal delivery of highly ionized fat insoluble drugs
ALZA CORP189 citations99
US4559222ADec 17, 1985
Matrix composition for transdermal therapeutic system
ALZA CORP238 citations99
US5620700AApr 15, 1997
Injectable drug delivery system and method
ALZA CORP186 citations98
US5342623AAug 30, 1994
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP144 citations98
US5004610AApr 2, 1991
Subsaturated nicotine transdermal therapeutic system
ALZA CORP166 citations98
US4938759AJul 3, 1990
Transdermal delivery device having a rate controlling adhesive
ALZA CORP140 citations98
US4908027AMar 13, 1990
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP174 citations98
US5783205AJul 21, 1998
Injectable drug delivery system and method
ALZA CORP118 citations97
US4820720AApr 11, 1989
Transdermal drug composition with dual permeation enhancers
ALZA CORP159 citations97
US4788062ANov 29, 1988
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
ALZA CORP231 citations97
US6165497ADec 26, 2000
Subsaturated nicotine transdermal therapeutic system
ALZA CORP58 citations96
US5364630ANov 15, 1994
Subsaturated nicotine transdermal therapeutic system
ALZA CORP87 citations96
US4573995AMar 4, 1986
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
ALZA CORP319 citations96
US5462745AOct 31, 1995
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP72 citations95
US5344656ASep 6, 1994
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP62 citations95
US4764379AAug 16, 1988
Transdermal drug delivery device with dual permeation enhancers
ALZA CORP69 citations95
US4832953AMay 23, 1989
Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
ALZA CORP100 citations94
US6007837ADec 28, 1999
Drug delivery devices and process of manufacture
ALZA CORP70 citations93
US6174545B1Jan 16, 2001
Drug delivery devices and process of manufacture
ALZA CORP9 citations71